Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded by Richard L. Franklin and Joerg Gruber on September 2, 2011 and is headquartered in Cambridge, MA.
Company profile
Ticker
PFND
Exchange
Website
CEO
Richard L. Franklin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Life Medical Sciences Inc, SyntheMed, Inc.
SEC CIK
Corporate docs
IRS number
141745197
Latest filings (excl ownership)
15-12G
Securities registration termination
30 Mar 16
EFFECT
Notice of effectiveness
30 Mar 16
8-K
Other Events
29 Mar 16
POS AM
Prospectus update (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Mar 16
EFFECT
Notice of effectiveness
28 Mar 16
Latest ownership filings